MeSH note : consists of the extracellular domain of FGF receptor 1c (FGFR1c) splice isoform fused
to the Fc (crystallizable fragment) region of human immunoglobulin G; in Phase II
trial (ClinicalTrials.gov identifier: NCT01244438) for endometrial cancers 5/2011;